soul trial oral semaglutide cardiovascular outcomes 2024 results 2025 Trial Scorecard: SOUL Oral Semaglutide and Cardiovascular Outcomes

PT-141+ Sublingual Strips feature a multi-compound formulation of PT-141 (2 mg per strip), Oxytocin (25 mcg per strip), and Aminophenpyrrole (20 mg per strip) in a fast-dissolving format, developed to support preclinical research into peptidesmall molecule interactions, compound compatibility, and presentation stability within controlled laboratory environments

Results showed that insulin levels two hours after an oral glucose tolerance test decreased significantly - by 22.18 mIU/L compared to metformin and by 51.72 mIU/L compared to placebo

The end product of this reaction (AGE), in turn, induce oxidative stress and accelerate the Maillard reactions ultimately leading to inflammation and the propagation of tissue damage [30, 31, 32]

10.1016/j.bbrc.2007.09.018 [DOI] [PubMed] [Google Scholar] Bradford M

The idea is to verify safety (and efficacy) without the cloud of bias that internal testing could introduce

But who guides your care matters just as much as the tools themselves